Stock Track | PROCEPT BioRobotics Plunges 23.13% in Pre-Market After Earnings Miss and Multiple Analyst Downgrades

Stock Track

Feb 26

PROCEPT BioRobotics (PRCT) experienced a significant pre-market plunge of 23.13% on Thursday, following disappointing quarterly results and subsequent analyst price target reductions.

The sharp decline comes after the company released its fourth-quarter 2025 financial results, which fell short of analyst expectations. PROCEPT reported a quarterly loss per share of $(0.53), missing the consensus estimate of $(0.32) by a wide margin. Revenue for the quarter was $76.383 million, also below the estimated $94.137 million. CEO Larry Wood stated that the revenue shortfall was due to strategic actions including a commercial organization realignment, the elimination of end-of-quarter purchasing incentives, and a more disciplined handpiece pricing strategy.

Following the earnings report, multiple analysts cut their price targets on the stock. TD Cowen maintained a Buy rating but reduced its target to $34 from $50, Jefferies cut its target to $30 from $39, and Leerink Partners slashed its target to $30 from $55. These downgrades contributed to the selling pressure in pre-market trading as investors reassessed the company's near-term prospects.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1159510488"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1159510488\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1159510488?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-26 18:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1159510488","market":"us","top_or_hot":-1,"title":"Stock Track | PROCEPT BioRobotics Plunges 23.13% in Pre-Market After Earnings Miss and Multiple Analyst Downgrades","media":"Stock Track","content":"<p>PROCEPT BioRobotics (PRCT) experienced a significant pre-market plunge of 23.13% on Thursday, following disappointing quarterly results and subsequent analyst price target reductions.</p><p>The sharp decline comes after the company released its fourth-quarter 2025 financial results, which fell short of analyst expectations. PROCEPT reported a quarterly loss per share of $(0.53), missing the consensus estimate of $(0.32) by a wide margin. Revenue for the quarter was $76.383 million, also below the estimated $94.137 million. CEO Larry Wood stated that the revenue shortfall was due to strategic actions including a commercial organization realignment, the elimination of end-of-quarter purchasing incentives, and a more disciplined handpiece pricing strategy.</p><p>Following the earnings report, multiple analysts cut their price targets on the stock. TD Cowen maintained a Buy rating but reduced its target to $34 from $50, Jefferies cut its target to $30 from $39, and Leerink Partners slashed its target to $30 from $55. These downgrades contributed to the selling pressure in pre-market trading as investors reassessed the company's near-term prospects.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | PROCEPT BioRobotics Plunges 23.13% in Pre-Market After Earnings Miss and Multiple Analyst Downgrades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | PROCEPT BioRobotics Plunges 23.13% in Pre-Market After Earnings Miss and Multiple Analyst Downgrades\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-26 18:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>PROCEPT BioRobotics (PRCT) experienced a significant pre-market plunge of 23.13% on Thursday, following disappointing quarterly results and subsequent analyst price target reductions.</p><p>The sharp decline comes after the company released its fourth-quarter 2025 financial results, which fell short of analyst expectations. PROCEPT reported a quarterly loss per share of $(0.53), missing the consensus estimate of $(0.32) by a wide margin. Revenue for the quarter was $76.383 million, also below the estimated $94.137 million. CEO Larry Wood stated that the revenue shortfall was due to strategic actions including a commercial organization realignment, the elimination of end-of-quarter purchasing incentives, and a more disciplined handpiece pricing strategy.</p><p>Following the earnings report, multiple analysts cut their price targets on the stock. TD Cowen maintained a Buy rating but reduced its target to $34 from $50, Jefferies cut its target to $30 from $39, and Leerink Partners slashed its target to $30 from $55. These downgrades contributed to the selling pressure in pre-market trading as investors reassessed the company's near-term prospects.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PRCT","symbol_name":"PROCEPT BioRobotics","start_time":0,"source_url":"","article_id":"1159510488","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1159510488","pubTimestamp":1772101117,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"PROCEPT BioRobotics (PRCT) experienced a significant pre-market plunge of 23.13% on Thursday, following disappointing quarterly results and subsequent analyst price target reductions.The sharp...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PRCT":"PROCEPT BioRobotics"},"translate_title":"个股追踪|PROCEPT BioRobotics盘前暴跌23.13%，此前财报未达预期且多位分析师下调评级","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PRCT":1},"content_text":"PROCEPT BioRobotics (PRCT) experienced a significant pre-market plunge of 23.13% on Thursday, following disappointing quarterly results and subsequent analyst price target reductions.The sharp decline comes after the company released its fourth-quarter 2025 financial results, which fell short of analyst expectations. PROCEPT reported a quarterly loss per share of $(0.53), missing the consensus estimate of $(0.32) by a wide margin. Revenue for the quarter was $76.383 million, also below the estimated $94.137 million. CEO Larry Wood stated that the revenue shortfall was due to strategic actions including a commercial organization realignment, the elimination of end-of-quarter purchasing incentives, and a more disciplined handpiece pricing strategy.Following the earnings report, multiple analysts cut their price targets on the stock. TD Cowen maintained a Buy rating but reduced its target to $34 from $50, Jefferies cut its target to $30 from $39, and Leerink Partners slashed its target to $30 from $55. These downgrades contributed to the selling pressure in pre-market trading as investors reassessed the company's near-term prospects.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}